You are here

Pfizer

Sangamo shares surge 3.4% on $12 mln ALS gene therapy collaboration with Pfizer

Marketwatch

Wed, 01/3/18 - 10:06 am

drug development

Pfizer, Valneva stand to gain from Sanofi's C. diff vaccine flop: report

Fierce Pharma

Tue, 01/2/18 - 07:21 pm

Oncology business to keep leading pharma market in 2018

GoinPharma

Wed, 12/27/17 - 09:39 am

Bristol-Myers Squibb

Merck, Pfizer make a late — very late — arrival at the SGLT2 party for diabetes

Endpoints

Thu, 12/21/17 - 10:07 am

SGLT2 inhibitor

Array Biopharma ties up with Pfizer on cancer-fighting combos

Fierce Biotech

Wed, 12/20/17 - 09:51 am

Array Biopharma

clinical trials

Pfizer, Exelixis cancer drugs get FDA approval for wider use

Reuters

Wed, 12/20/17 - 09:39 am

A New PARP Drug For Breast Cancer

Forbes

Mon, 12/18/17 - 10:13 am

PARP inhibitors

metastatic breast cancer

Here's Why GlycoMimetics Could Become a Takeover Target

Yahoo/Motley Fool

Sun, 12/17/17 - 11:36 am

acute myeloid leukemia

Pfizer takes on Novartis, Lilly with Xeljanz psoriatic arthritis approval

Fierce Pharma

Fri, 12/15/17 - 11:27 pm

psoriatic arthritis

Pfizer Not Planning US Launch of its Second Remicade Biosimilar Approved by FDA

RAPS.org

Fri, 12/15/17 - 09:36 am

Pfizer's second biosimilar of J&J's Remicade wins U.S. FDA approval

Yahoo/Reuters

Thu, 12/14/17 - 09:18 am

rheumatoid arthritis

Crohn's Disease

Why 2017 Was a Year to Forget for Pfizer Inc.

Yahoo/Motley Fool

Wed, 12/13/17 - 09:39 am

[forum discussion]Pfizer Jumps the Shark over Biosimilar Failure

Cafepharma Message Boards

Tue, 12/12/17 - 11:14 am

Roche's Fight With Pfizer May Be Just The Beginning

Forbes

Mon, 12/11/17 - 11:31 pm

Men near the Viagra plant may be excited, but it’s not because of ‘love fumes,’ Pfizer says

Miami Herald, FL

Mon, 12/11/17 - 11:15 pm

drug manufacturing

In a showdown with AstraZeneca, Pfizer posts solid — and very familiar — PhIII breast cancer data for talazoparib

Endpoints

Fri, 12/8/17 - 11:46 am

advanced breast cancer

PARP inhibitors

Spark, Pfizer pass another milestone with impressive results treating hemophilia B

Endpoints

Thu, 12/7/17 - 09:14 am

Spark Therapeutics

Pfizer Accuses J&J of Anticompetitive Business Practices over Remicade Biosimilar

JD Supra

Thu, 12/7/17 - 09:07 am

anticompetitive practices

Viagra goes generic: Pfizer to launch own little white pill

CNBC/AP

Wed, 12/6/17 - 11:55 pm

erectile dysfunction

Republican tax bill makes big winners of Amgen, Gilead and other drugmakers

Marketwatch

Wed, 12/6/17 - 09:48 am

Gilead Sciences

offshore accounts

Pages